CBU
MDLN

CIBC Bancorp USA’s Medline Inc MDLN Stock Holding History

CIBC Bancorp USA’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$593K Buy
+15,028
New +$606K ﹤0.01% 1252

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

CIBC Bancorp USA's MDLN Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Medline Inc (MDLN) in Q2 2026: 15,028 shares worth $593K. The stake represents ﹤0.01% of the portfolio and ranks #1252 among its holdings.

376 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • CIBC Bancorp USA held 15,028 shares of Medline Inc worth $593K as of Q2 2026.
  • Medline Inc was a new CIBC Bancorp USA position in Q2 2026.
  • Medline Inc made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1252 holding.
  • 376 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.